The Phase 3 ECLIPSE clinical trial evaluates lutetium-177 (Lu-177) zadavotide guraxetan (a proprietary formulation of 177 Lu-PSMA-I&T), an investigational prostate-specific membrane antigen ...
Fagron, the leading global player in pharmaceutical compounding, announces that it has completed the acquisition of Pharmavit Europe, a leading European distributor of nutraceutical raw materials ...
NANTES, France, February 26, 2026 – 6pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced that the Independent Data Monitoring Committee (IDMC) has issued a second ...
The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report fourth quarter and full year 2025 financial results after market close on Thursday, March ...
Survey of 700+ executives shows AI leadership roles surging as succession planning and clinician engagement lag DALLAS, Feb. 26, 2026 (GLOBE NEWSWIRE) -- While nearly three-quarters of healthcare ...
Flourish Research ® today announced a strategic partnership with Capitol Imaging Services in advance of the launch of Flourish Imaging™, an advanced imaging center currently under development in ...
Oxford Healthspan is the only non-Japanese member of the Japan Autophagy Consortium, which has established a new certification program for supplements that claim to activate autophagy. The ...
Regeneron will extend its title sponsorship of the Regeneron Science Talent Search (STS) for a second decade, continuing its partnership with Society for Science to support the United States’ oldest ...
“Our surgeons are making a tremendous difference in countries all over the world, and we’re honored to be a part of that process,” said USOSM CEO Doug Drew. “We commend Dr. Liao on her medical mission ...
The passing of Rev. Jesse L. Jackson, Sr. has cast a spotlight on progressive supranuclear palsy (PSP), one of the most misunderstood neurodegenerative diseases affecting Americans today. As tributes ...
Early adopters of the activL Lumbar Disc have expressed strong confidence in the technology and its clinical performance. This milestone marks a significant expansion of the Highridge Medical ...
Sun Pharma has the right to request a review of the decision or appeal it to the United States Court of Appeals for the Federal Circuit. The decision does not affect the petition filed by the Company ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results